BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12213121)

  • 1. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    Ei Korchi G; Prats C; Arboix M; Pérez B
    J Vet Pharmacol Ther; 2002 Aug; 25(4):317. PubMed ID: 12213121
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    Lees P; Gettinby G; Toutain PL
    J Vet Pharmacol Ther; 2002 Jun; 25(3):237-8. PubMed ID: 12081620
    [No Abstract]   [Full Text] [Related]  

  • 3. Disposition of oxytetracycline in pigs after i.m. administration of two long-acting formulations.
    El Korchi G; Prats C; Arboix M; Pérez B
    J Vet Pharmacol Ther; 2001 Aug; 24(4):247-50. PubMed ID: 11555179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of long-acting oxytetracycline in fallow deer (Dama dama).
    Haigh JC; Dowling PM; Smits JG
    J Vet Pharmacol Ther; 1997 Jun; 20(3):243-5. PubMed ID: 9185093
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacokinetics of a long-acting oxytetracycline formulation in healthy dogs and in dogs infected with Ehrlichia canis.
    Kikuvi GM; Mitema ES; Buoro IB
    Vet Res Commun; 2001 Jul; 25(5):391-400. PubMed ID: 11469510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum oxytetracycline concentrations in African elephant (Loxodonta africana) calves after long-acting formulation injection.
    Bush M; Stoskopf MK; Raath JP; Papich MG
    J Zoo Wildl Med; 2000 Mar; 31(1):41-6. PubMed ID: 10884122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Short- and Long-acting Formulations of Oxytetracycline After Intramuscular Administration in Chickens.
    Gberindyer AF; Okpeh ER; Semaka AA
    J Avian Med Surg; 2015 Dec; 29(4):298-302. PubMed ID: 26771319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between oral fluid and plasma oxytetracycline concentrations after intramuscular administration in pigs.
    Gajda A; Jablonski A; Gbylik-Sikorska M; Posyniak A
    J Vet Pharmacol Ther; 2017 Dec; 40(6):e39-e44. PubMed ID: 28456999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses.
    Dowling PM; Russell AM
    J Vet Pharmacol Ther; 2000 Apr; 23(2):107-10. PubMed ID: 10849256
    [No Abstract]   [Full Text] [Related]  

  • 10. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of a long-acting oxytetracycline formulation in Thai swamp buffaloes (Bubalus bubalis).
    Poapolathep S; Wongpanit K; Imsilp K; Tanhan P; Klangkaew N; Giorgi M; Poapolathep A
    J Vet Pharmacol Ther; 2017 Apr; 40(2):206-209. PubMed ID: 27597645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of a long-acting formulation of oxytetracycline in sheep and goats.
    Escudero E; Carceles CM; Ponferrada C; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):75-7. PubMed ID: 8992031
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
    Banting AL; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of oxytetracycline after intravenous administration at two dose levels to hens.
    Moreno L; Serrano JM; Reja A; Guimera E; Escudero E
    J Vet Pharmacol Ther; 1996 Dec; 19(6):495-7. PubMed ID: 8971681
    [No Abstract]   [Full Text] [Related]  

  • 15. Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves.
    Kumar R; Malik JK
    Vet Res Commun; 1998 Dec; 22(8):533-44. PubMed ID: 10066127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oxytetracycline administered intravenously to 4 to 5-day-old foals.
    Papich MG; Wright AK; Petrie L; Korsrud GO
    J Vet Pharmacol Ther; 1995 Oct; 18(5):375-8. PubMed ID: 8587157
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic disposition of a long-acting oxytetracycline formulation after single-dose intravenous and intramuscular administrations in the American alligator (Alligator mississippiensis).
    Helmick KE; Papich MG; Vliet KA; Bennett RA; Jacobson ER
    J Zoo Wildl Med; 2004 Sep; 35(3):341-6. PubMed ID: 15526889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of oxytetracycline in biological matrix.
    Kowalski C; Pomorska M; Lebkowska B; Sławik T
    Acta Pol Pharm; 2006; 63(5):409-11. PubMed ID: 17357597
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of two long-acting oxytetracycline products administered subcutaneously and intramuscularly.
    Clarke CR; Wang Z; Cudd L; Burrows GE; Kirkpatrick JG; Brown MD
    J Vet Pharmacol Ther; 1999 Feb; 22(1):65-7. PubMed ID: 10211720
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma bioavailability of 2 long-acting oxytetracycline formulations in the pig.
    Archimbault P; Navetat H; Vidal R; Douin MJ; Mignot A
    Vet Res; 1994; 25(4):399-404. PubMed ID: 8087147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.